Top of page

Student/Staff Portal
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation
You are here: Main Content
  • An image showing the intestine with magnifying glass zooming in

    A healthy gut can substantially improve physical and mental wellbeing.

Related Contents

Does Enzyme Rich Malt Extract improve symptoms and quality of life for those with Irritable Bowel Syndrome?

Irritable Bowel Syndrome (IBS) affects 1 in 10 adults globally, often affecting both physical and mental wellbeing, and reducing overall quality of life. There are also significant economic and social consequences incurred by IBS, costing the country in absenteeism, medication and treatment. Researchers believe one potential underlying cause of IBS is driven by inefficient digestion of carbohydrates in the small intestine. A newly developed malt-based product is the first to try and address this and thereby reduce the symptoms of IBS by optimising carbohydrate metabolism, potentially also leading to an improvement in the gut microbiome. ECU researchers are therefore hoping it will help alleviate part of the burden associated with IBS.

The Research

A multidisciplinary team of researchers from ECU’s School of Medical and Health Sciences, are coordinating a clinical trial to evaluate the effects of a novel enzyme rich malt extract on gut health and quality of life in adults with IBS. The cross-over design study is looking for 50 participants between 18 and 65 years old, who have been clinically diagnosed with IBS. Eligible participants will be provided with either an enzyme rich malt extract, or a control malt extract supplement, and asked to supplement daily for a 4-week period. Before and after the interventions, subjects will be asked to provide stool and blood samples, complete a three-day diet record, and questionnaires relating to quality of life. Throughout the study, participants will monitor their IBS related symptoms via a bowel symptom survey. If effective, the enzyme rich malt extract may be an exciting prospect toward non-invasive treatment for IBS sufferers.

Funding Body

Ateria Health Ltd.

Researchers

Associate Professor Chris Abbiss

Professor Amanda Devine

Dr Claus Christophersen

Dr. Rachel McCormick (Research Assistant)

Michael Furfaro (Research Assistant)

Tina Yan (PhD candidate)

Bronwen Charlesson (PhD candidate)

Contact

If you are interested in participating, or have further questions, please contact Dr. Rachel McCormick and Michael Furfaro on 0417 915 881 or rachel.mccormick@ecu.edu.au

Skip to top of page